Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine

Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are actively carried out around the world. Several vaccines are currently approved for emergency use in the population, while ongoing studies continue to provide information on their safety and eff...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Luisa F. Duarte, Nicolás M. S. Gálvez, Carolina Iturriaga, Felipe Melo-González, Jorge A. Soto, Bárbara M. Schultz, Marcela Urzúa, Liliana A. González, Yaneisi Vázquez, Mariana Ríos, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Daniela Moreno-Tapia, Gaspar A. Pacheco, Omar P. Vallejos, Guillermo Hoppe-Elsholz, María S. Navarrete, Álvaro Rojas, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Susan M. Bueno, Alexis M. Kalergis
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2021-09-01
Цуврал:	Frontiers in Immunology
Нөхцлүүд:	CoronaVac phase 3 clinical trial SARS-CoV-2 COVID-19 vaccines breakthrough cases
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.742914/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!